A Phase II feasibility study of oral etoposide given concurrently with radiotherapy followed by dose intensive adjuvant chemotherapy for children with newly diagnosed high-risk medulloblastoma (protocol POG 9631): A report from the Children's Oncology Gro-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Phase II feasibility study of oral etoposide given concurrently with radiotherapy followed by dose intensive adjuvant chemotherapy for children with newly diagnosed high-risk medulloblastoma (protocol POG 9631): A report from the Children's Oncology Gro

Published:2016-12-21 Issue:6 Volume:64 Page:e26373
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Esbenshade Adam J.¹,Kocak Mehmet²,Hershon Linda³,Rousseau Pierre³,Decarie Jean-Claude³,Shaw Susan⁴,Burger Peter⁵,Friedman Henry S.⁶,Gajjar Amar⁷,Moghrabi Albert⁸

Affiliation:

1. Monroe Carrell Jr. Children's Hospital at Vanderbilt, Vanderbilt Ingram Cancer Center; Nashville Tennessee

2. University of Tennessee Health Science Center; Memphis Tennessee

3. Centre Hospitalier Universitaire Sainte-Justine; Montreal Quebec Canada

4. State University of New York Upstate Medical University; Syracuse New York

5. Johns Hopkins University; Baltimore Maryland

6. Duke University Medical Center; Durham North Carolina

7. St. Jude Children's Research Hospital; Memphis Tennessee

8. Centre Hospitalier de Verdun; Montreal Quebec Canada

Funder

NIH-Statistics and Data Center Grant

Chair's Grant

NCTN Operations Center Grant

NCTN Statistics & Data Center

National Cancer Institute

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference20 articles.

1. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011;Ostrom;Neuro Oncol,2014

2. A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children's Oncology Group (CCG 9931);Allen;Int J Radiat Oncol Biol Phys,2009

3. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial;Gajjar;Lancet Oncol,2006

4. Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology Group Phase I/II study;Jakacki;J Clin Oncol,2012

5. Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children's Oncology Group trial A9961;Packer;Neuro Oncol,2013

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution of Systemic Therapy in Medulloblastoma Including Irradiation-Sparing Approaches;Diagnostics;2023-12-16

2. Brain Tumors in Adolescents and Young Adults: A Review;Seminars in Neurology;2023-11-10

3. Life Experience of Chinese Pediatric Medulloblastoma Survivors: A Qualitative Study;Journal of Neuroscience Nursing;2023-10

4. Posterior fossa tumors in children: current insights;European Journal of Pediatrics;2023-09-08

5. Questions and answers in the management of children with medulloblastoma over the time. How did we get here? A systematic review;Frontiers in Oncology;2023-06-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3